ArticleNutrients2026
Serum Vitamin A in Relation to Genomic Biomarkers in Children: A Prospective Study.
Article in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
BACKGROUND/
objectivesVitamin A (VA), which is fat-soluble, belongs to the group of carotenoids, a class of highly effective antioxidant and genoprotective compounds (including astaxanthine, zeaxanthine, luteine). It plays a critical role in cellular growth, differentiation, and oxidative stress regulation, but prospective evidence linking childhood VA to subsequent genomic stability is scarce. This study investigated whether baseline VA levels were associated with later measurements of relative telomere length (RTL), four ribosomal DNA copy numbers (rDNA-CN: 5S, 18S, 28S, and 45S), and mitochondrial DNA copy number (mtDNA-CN) in children over a 4-year follow-up.
methodsBaseline VA levels were measured in 2021. In 2025, peripheral blood genomic DNA was extracted, and RTL, rDNA-CNs, and mtDNA-CN were quantified using qPCR. Multivariable linear regression and restricted cubic spline regression (RCS) were employed to examine the associations and dose-response shapes. Sex-stratified analyses with interaction tests were performed to evaluate effect modification by sex.
resultsAmong 215 children, baseline VA was positively associated with RTL, 5S rDNA-CN, 18S rDNA-CN, and 45S rDNA-CN after covariate adjustment. RCS analyses revealed strictly monotonic positive dose-response curves between VA and RTL, 5S rDNA-CN, and 18S rDNA-CN, with no statistically significant sex interaction (all
conclusionsHigher childhood VA levels are positively associated with longer telomeres and higher rDNA-CN in later childhood, suggesting that adequate early-life VA may confer long-term benefits for ribosomal genomic stability and cellular aging. These observations expand our understanding of nutrition-related modulators of child genomic homeostasis and support further investigation into nutritional interventions targeting genomic protection in early life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.